About Devanjali Pharma Private Limited
Data last updated:
Devanjali Pharma Private Limited is a private limited company based in Rajkot, Gujarat, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 21 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2016PTC092568. Its GSTIN is 24AAFCD7657N1Z4 (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Samir Bhupatrai Gohel and Parul Pranav Unadkat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 41 Shri Hari Industrial Park, Rajkot, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.24 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹2.87 Lakh (net margin 1.3%) and EBITDA of ₹4.6 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 45% over five years.
The company is associated with 1 brand: Devanjali.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website devanjalipharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No 41 Shri Hari Industrial Park, Sokhda, Rajkot, Gujarat, India – 360003
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Devanjali Pharma Private Limited
Devanjali Pharma operates one associated brand: Devanjali. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Herbal and allopathy products manufacturing and distribution in India. | devanjalipharma.com |
Business Activity of Devanjali Pharma Private Limited
The main business activity of Devanjali Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Devanjali Pharma Private Limited FY 2025 filings available
Devanjali Pharma Private Limited reported revenue of ₹2.24 Cr (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Devanjali Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 45% over five years, including 26% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Devanjali Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.6 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.87 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Devanjali Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Devanjali Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Devanjali Pharma Private Limited
Devanjali Pharma has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samir Bhupatrai Gohel | Director | 21 Jun 2016 | 10 Years 4 Months | Current |
| Parul Pranav Unadkat | Director | 21 Jun 2016 | 10 Years 4 Months | Current |
| Dharmishthaben Pragneshbhai Suchak | Director | 21 Jun 2016 | 10 Years 4 Months | Current |
| Jitendrakumar Jayvantbhai Panchamiya Also directs: Rapier Pharmaceutical Private Limited | Director | 21 Jun 2016 | 10 Years 4 Months | Current |
| Deepaben Omkumar Butani | Director | 21 Jun 2016 | 10 Years 4 Months | Current |
Peer Comparison of Devanjali Pharma Private Limited
Devanjali Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Birla Healthcare Ayurveda Private Limited | ₹2.26 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Mumbai, Maharashtra, India |
| Old Forests Ayurved Private Limited | ₹2.25 Cr (FY 2024) | •••• | •••• | 59.0% | •••• | Karnal, Haryana, India |
| Tymon Healthcare Private Limited | ₹2.25 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Ludhiana, Punjab, India |
| Vilasita Aromaceuticals Private Limited | ₹2.25 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Faridabad, Haryana, India |
| Ankerite Health Care Private Limited | ₹2.24 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Lucknow, Uttar Pradesh, India |
| Devanjali Pharma Private Limited this company | ₹2.24 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Rajkot, Gujarat, India |
| Nogi & Company Private Limited | ₹2.23 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Mehta Pharmaceuticals Private Limited | ₹2.23 Cr (FY 2024) | •••• | •••• | -71.0% | •••• | Amritsar, Punjab, India |
| Pragati Bio-Pharma Private Limited | ₹2.2 Cr (FY 2024) | •••• | •••• | -31.0% | •••• | Hyderabad, Telangana, India |
| Hanuved Ayurveda Private Limited | ₹2.2 Cr (FY 2024) | •••• | •••• | 156.0% | •••• | Delhi, India |
| Bluephoenix Herbal Sciences Private Limited | ₹2.2 Cr (FY 2025) | •••• | •••• | 254.0% | •••• | Dehradun, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Devanjali Pharma by revenue in the Healthcare industry (Ayurvedic Products and Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Devanjali Pharma Private Limited
Devanjali Pharma Private Limited is audited by VIJAY POPAT & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIJAY POPAT & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Devanjali Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Devanjali Pharma Private Limited
Devanjali Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Devanjali Pharma Private Limited
Employment history and EPFO contributions of people linked to Devanjali Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Devanjali Pharma Private Limited
Devanjali Pharma Private Limited has 5 board changes on record since 2016: 5 appointments. The latest: Deepaben Omkumar Butani was appointed as Director on 21 Jun 2016.
Credit Ratings, Litigation & Regulatory Alerts for Devanjali Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Devanjali Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Devanjali Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Devanjali Pharma Private Limited
Devanjali Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCD7657N1Z4 | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Devanjali Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devanjali Pharma Private Limited
Devanjali Pharma is an active private limited company based in Rajkot, Gujarat, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 21 June 2016 (10+ years old) and is registered under CIN U74999GJ2016PTC092568.
Devanjali Pharma reported revenue of ₹2.24 Cr for FY 2025 (up 26% YoY).
Devanjali Pharma has 5 current directors:
- Samir Bhupatrai Gohel - Director
- Parul Pranav Unadkat - Director
- Dharmishthaben Pragneshbhai Suchak - Director
- Jitendrakumar Jayvantbhai Panchamiya - Director
- Deepaben Omkumar Butani - Director
Devanjali Pharma reported a net profit of ₹2.87 Lakh (net margin 1.3%) and EBITDA of ₹4.6 Lakh (EBITDA margin 2.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Devanjali Pharma is 38% over three years and 45% over five years. In the latest year (FY 2025) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Devanjali Pharma is 24AAFCD7657N1Z4, registered in Gujarat.
The CIN (Corporate Identification Number) of Devanjali Pharma is U74999GJ2016PTC092568. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Devanjali Pharma was incorporated on 21 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Devanjali Pharma by revenue are Birla Healthcare Ayurveda Private Limited, Old Forests Ayurved Private Limited, Tymon Healthcare Private Limited, Vilasita Aromaceuticals Private Limited, Ankerite Health Care Private Limited and 5 more, all in the Healthcare industry (Ayurvedic Products and Services).
Deepaben Omkumar Butani was appointed as Director on 21 Jun 2016. Dharmishthaben Pragneshbhai Suchak was appointed as Director on 21 Jun 2016. Jitendrakumar Jayvantbhai Panchamiya was appointed as Director on 21 Jun 2016. Devanjali Pharma has 5 board changes on record in total.
Devanjali Pharma can be reached through the website devanjalipharma.com. Its registered office is in Rajkot, Gujarat, India.